Twist Bioscience Corporation
TWST · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $99,009 | $96,057 | $92,793 | $88,713 |
| % Growth | 3.1% | 3.5% | 4.6% | – |
| Cost of Goods Sold | $48,172 | $44,760 | $46,765 | $45,873 |
| Gross Profit | $50,837 | $51,297 | $46,028 | $42,840 |
| % Margin | 51.3% | 53.4% | 49.6% | 48.3% |
| R&D Expenses | $17,014 | $18,047 | $23,917 | $21,307 |
| G&A Expenses | $56,757 | $0 | $0 | $0 |
| SG&A Expenses | $63,758 | $63,370 | $63,671 | $56,177 |
| Sales & Mktg Exp. | $7,000 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $80,772 | $81,417 | $87,588 | $77,484 |
| Operating Income | -$29,935 | -$30,120 | -$41,560 | -$34,644 |
| % Margin | -30.2% | -31.4% | -44.8% | -39.1% |
| Other Income/Exp. Net | $3,053 | $50,701 | $2,407 | $3,147 |
| Pre-Tax Income | -$26,882 | $20,581 | -$39,153 | -$31,497 |
| Tax Expense | $256 | $191 | $175 | $97 |
| Net Income | -$27,138 | $20,390 | -$39,328 | -$31,594 |
| % Margin | -27.4% | 21.2% | -42.4% | -35.6% |
| EPS | -0.45 | 0.34 | -0.66 | -0.53 |
| % Growth | -232.4% | 151.5% | -24.5% | – |
| EPS Diluted | -0.45 | 0.33 | -0.66 | -0.53 |
| Weighted Avg Shares Out | 60,424 | 59,995 | 59,649 | 59,162 |
| Weighted Avg Shares Out Dil | 60,424 | 61,164 | 59,649 | 59,162 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2,633 | $2,690 | $2,801 | $3,240 |
| Interest Expense | $0 | $0 | $143 | $24 |
| Depreciation & Amortization | $6,004 | $5,800 | $6,404 | $6,380 |
| EBITDA | -$20,878 | $26,381 | -$32,606 | -$25,093 |
| % Margin | -21.1% | 27.5% | -35.1% | -28.3% |